Loading insider details...
Beta
Latest Form 4 (Oct 19, 2026): Conversion of 192,579 IAM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | Iambic Therapeutics, Inc. (IAM) | Conversion | 192,579 | n/a |
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | Grant/Award | 40,600 | n/a |
| Jul 2, 2026 | Dare Bioscience, Inc. (DARE) | Grant/Award | 38,862 | n/a |
| Jun 15, 2026 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 87,900 | n/a |
| Jun 11, 2026 | Dare Bioscience, Inc. (DARE) | Grant/Award | 10,000 | n/a |
| May 29, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/Award | 2,567 | n/a |
| May 21, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 3,318 | n/a |
| May 6, 2026 | FATE THERAPEUTICS INC (FATE) | Exercise/Conversion | 25,000 | $42.3K |
| Nov 6, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 18,000 | $862.0K |
| Jul 10, 2025 | Dare Bioscience, Inc. (DARE) | Grant/Award | 4,500 | n/a |